Johnson, Michael P.
Eli Lilly (United States)
3 papers on CoChatORCID 0000-0001-6164-3569
Most cited papers
- Verified
Metabotropic glutamate receptors as novel targets for anxiety and stress disorders
Swanson, C. J., Bures, M., Johnson, M. P., Linden, A.-M., Monn, J. A., & Schoepp, D. D. (2005) · Nature Reviews Drug Discovery
Neuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on Behavior
Cited by 607
- Verified
Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s)
Johnson, M. P., Barda, D., Britton, T. C., Emkey, R., Hornback, W. J., Jagdmann, G. E., McKinzie, D. L., Nisenbaum, E. S., Tizzano, J. P., & Schoepp, D. D. (2005) · Psychopharmacology
Neuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling
Cited by 156
- Verified
Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis
Schuelert, N., Johnson, M. P., Oskins, J. L., Jassal, K., Chambers, M. G., & McDougall, J. J. (2011) · Pain
Cannabis and Cannabinoid ResearchPain Mechanisms and Treatments
Cited by 70
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free